Lexology December 29, 2023
Reed Smith LLP

Another year bites the dust. We have just about made it through 2023, and while we have compiled our annual top ten best prescription medical product liability litigation decisions, we have the same sense with these as we did with last week’s bottom ten – in 2023 the favorable (as well as unfavorable) results from our product liability sandbox were rather overshadowed by impactful decisions elsewhere Eligibility for our top (or bottom) ten lists requires that the decision: (1) involve a prescription medical product, or OTC drug, and (2) have a plaintiff asserting liability for something purportedly wrong with that product.

In 2023 there seemed to be an unusually large number of other decisions that are likely to have a...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: Biotechnology, Medical Devices, Pharma, Pharma / Biotech
Pharma Firms Mallinckrodt and Endo Agree to Merge in $6.7B Cash and Stock Deal
FDA Approves First Biosimilar to Omalizumab
Zealand Pharma, Roche Reach Potential $5.3 Billion Deal to Develop Petrelintide for Weight Management
STAT+: Pharmalittle: We’re reading about a Roche deal for an obesity drug, a Gilead HIV drug and more
Roche builds in obesity with $5.3bn Zealand licensing deal

Share This Article